Things categorized as 'Uncategorized'
Layoffs and Such
I promise... they posting will return next week. Due to the recent layoff at my company, I'm going to have plenty of time to ...
Astellas Proposes to Acquire CV Therapeutics for $1B
Astellas announced that it has submitted a proposal to the Board of Directors of CV Therapeutics to acquire all ...
Apologies About the Pharmababble Feed
I had some technical problems with the new site layout and my feed was spewing press releases (i.e.; i didn't know what I was doing ...
Biotech Committed Equity Financing Facility
I can't tell you why this seems to be the year of CEFFs (committed equity financing facility) but it can't be argued otherwise. As ...
Biomed Funding Roudup: Week Ending 8.1.08
ReGen Biologics Closes $2.5 Million Private Placement and Announces New 510(k) Submission to the FDA ReGen Biologics is an orthopedic products company that develops, manufactures ...
PTC Inks $437M Gene Therapy Deal With Genzyme
Image via Wikipedia Talk about a good week for PTC. A day after announcing the Cystic Fibrosis Foundation is ...
Secretive Agios Makes Splash with $33M Series A
Image via Wikipedia Agios Pharmaceuticals, backed by heavy hitters: Third Rock, Flagship and ARCH venture groups, announced it has closed a hefty, $33M Read More →
Biopharm Closing Bell: 6.13.08
Top Movers Generated 4 hours ago Gainers (% price change) Last Trade Change Mkt Cap Sequenom, Inc. SQNM 14.94 +2.10 (16.36%) 678.38M Chindex Intl, Inc. CHDX 16.32 +1.72 (11.78%) 203.22M Helicos BioSciences Corp. HLCS 4.96 +0.52 (11.71%) 103.84M DexCom, Inc. DXCM 8.00 +0.77 (10.65%) 235.80M Bio-Imaging Tech, Inc. BITI 7.25 +0.66 (10.02%) 103.33M Losers ...
Genentech and Symphogen Team Up For $330M
Image via Wikipedia I try not to be biased, but it's not too often I discuss danish biotech companies on this blog. Today ...
Drug Development: From Discovery to NDA
Introduction The time it takes from starting a program to selling a product can vary but is usually estimated to be around 10 years and ...
Biopharm Closing Bell: 6.6.08
Highlights: Inspire up on positive phase 3 results in a cystic fibrosis trial Have a great weekend. Gainers (% price change) Last Trade Change Mkt Cap Inspire ...
Biopharma Closing Bell: 6.5.08
Gainers (% price change) Last Trade Change Mkt Cap Tercica, Inc. TRCA 8.80 +4.39 (99.55%) 453.94M Sequenom, Inc. SQNM 11.15 +1.82 (19.51%) 506.28M XTL Biopharmaceuticals XTLB 3.45 +0.47 (15.77%) 100.97M Metabolix, Inc. MBLX 13.23 +1.75 (15.24%) 300.68M Cell Genesys, Inc. CEGE 3.67 +0.47 (14.69%) 289.03M Losers (% price ...
Guide to Financial Statements: Intro
The Basics One of the first things you should do if you want to get into the business side of biotechnology is familiarize yourself with financial ...